<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31444357</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>3827</StartPage><MedlinePgn>3827</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3827</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-019-11837-y</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of unknown etiology. Although defects in nucleocytoplasmic transport (NCT) may be central to the pathogenesis of ALS and other neurodegenerative diseases, the molecular mechanisms modulating the nuclear pore function are still largely unknown. Here we show that genetic and pharmacological modulation of actin polymerization disrupts nuclear pore integrity, nuclear import, and downstream pathways such as mRNA post-transcriptional regulation. Importantly, we demonstrate that modulation of actin homeostasis can rescue nuclear pore instability and dysfunction caused by mutant PFN1 as well as by C9ORF72 repeat expansion, the most common mutation in ALS patients. Collectively, our data link NCT defects to ALS-associated cellular pathology and propose the regulation of actin homeostasis as a novel therapeutic strategy for ALS and other neurodegenerative diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giampetruzzi</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danielson</LastName><ForeName>Eric W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gumina</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Istituto Auxologico Italiano, IRCCS, Department of Neurology - Stroke Unit and Laboratory of Neuroscience, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Maryangel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boopathy</LastName><ForeName>Sivakumar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Robert H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratti</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituto Auxologico Italiano, IRCCS, Department of Neurology - Stroke Unit and Laboratory of Neuroscience, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landers</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fallini</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worcester, MA, 01605, USA. cfallini@uri.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000178">Acrylamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000199">Actins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019086">Bridged Bicyclo Compounds, Heterocyclic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C586831">KPT-276</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495738">PFN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051304">Profilins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013844">Thiazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053778">Thiazolidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>SRQ9WWM084</RegistryNumber><NameOfSubstance UI="C037067">latrunculin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000178" MajorTopicYN="N">Acrylamides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000199" MajorTopicYN="N">Actins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019086" MajorTopicYN="N">Bridged Bicyclo Compounds, Heterocyclic</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004622" MajorTopicYN="N">Embryo, Mammalian</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046529" MajorTopicYN="N">Microscopy, Electron, Transmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022022" MajorTopicYN="N">Nuclear Pore</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051304" MajorTopicYN="N">Profilins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013844" MajorTopicYN="N">Thiazoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053778" MajorTopicYN="N">Thiazolidines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31444357</ArticleId><ArticleId IdType="pmc">PMC6707192</ArticleId><ArticleId IdType="doi">10.1038/s41467-019-11837-y</ArticleId><ArticleId IdType="pii">10.1038/s41467-019-11837-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chou C-C, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita Y, et al. Nuclear contour irregularity and abnormal transporter protein distribution in anterior horn cells in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2009;68:1184&#x2013;1192. doi: 10.1097/NEN.0b013e3181bc3bec.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181bc3bec</ArticleId><ArticleId IdType="pubmed">19816199</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. 2006;112:673&#x2013;680. doi: 10.1007/s00401-006-0130-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0130-4</ArticleId><ArticleId IdType="pubmed">16957927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert J, et al. FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins. Hum. Mol. Genet. 2018;27:4103&#x2013;4116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240733</ArticleId><ArticleId IdType="pubmed">30379317</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, et al. Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res. 2012;1462:3&#x2013;15. doi: 10.1016/j.brainres.2012.02.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.059</ArticleId><ArticleId IdType="pmc">PMC3707312</ArticleId><ArticleId IdType="pubmed">22444279</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronshaw JM, Matunis MJ. The nuclear pore complex: disease associations and functional correlations. Trends Endocrinol. Metab. 2004;15:34&#x2013;39. doi: 10.1016/j.tem.2003.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2003.11.005</ArticleId><ArticleId IdType="pubmed">14693424</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamali T, Jamali Y, Mehrbod M, Mofrad MRK. Nuclear pore complex: biochemistry and biophysics of nucleocytoplasmic transport in health and disease. Int Rev. Cell Mol. Biol. 2011;287:233&#x2013;286. doi: 10.1016/B978-0-12-386043-9.00006-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-386043-9.00006-2</ArticleId><ArticleId IdType="pubmed">21414590</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo MA, Raices M, Panowski SH, Hetzer MW. Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell. 2009;136:284&#x2013;295. doi: 10.1016/j.cell.2008.11.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.11.037</ArticleId><ArticleId IdType="pmc">PMC2805151</ArticleId><ArticleId IdType="pubmed">19167330</ArticleId></ArticleIdList></Reference><Reference><Citation>Savas JN, Toyama BH, Xu T, Yates JR, Hetzer MW. Extremely long-lived nuclear pore proteins in the rat brain. Science. 2012;335:942. doi: 10.1126/science.1217421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1217421</ArticleId><ArticleId IdType="pmc">PMC3296478</ArticleId><ArticleId IdType="pubmed">22300851</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerner AC, et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science. 2016;351:173&#x2013;176. doi: 10.1126/science.aad2033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad2033</ArticleId><ArticleId IdType="pubmed">26634439</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. Stress granule assembly disrupts nucleocytoplasmic transport. Cell. 2018;173:958&#x2013;971.e17. doi: 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 2004;14:461&#x2013;469. doi: 10.1016/j.tcb.2004.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2004.07.003</ArticleId><ArticleId IdType="pubmed">15308213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C-H, et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, et al. Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiol. Aging. 2015;36:1602.e17&#x2013;27. doi: 10.1016/j.neurobiolaging.2014.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.032</ArticleId><ArticleId IdType="pmc">PMC4357530</ArticleId><ArticleId IdType="pubmed">25499087</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron. 2014;84:324&#x2013;331. doi: 10.1016/j.neuron.2014.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.027</ArticleId><ArticleId IdType="pmc">PMC4521390</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283.e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Boopathy S, et al. Structural basis for mutation-induced destabilization of profilin 1 in ALS. Proc. Natl Acad. Sci. USA. 2015;112:7984&#x2013;7989. doi: 10.1073/pnas.1424108112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1424108112</ArticleId><ArticleId IdType="pmc">PMC4491777</ArticleId><ArticleId IdType="pubmed">26056300</ArticleId></ArticleIdList></Reference><Reference><Citation>Fil D, et al. Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Hum. Mol. Genet. 2017;26:686&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968635</ArticleId><ArticleId IdType="pubmed">28040732</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, et al. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proc. Natl Acad. Sci. USA. 2016;113:E6209&#x2013;E6218. doi: 10.1073/pnas.1605964113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605964113</ArticleId><ArticleId IdType="pmc">PMC5068285</ArticleId><ArticleId IdType="pubmed">27681617</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J. Cell Biol. 2002;158:915&#x2013;927. doi: 10.1083/jcb.200206106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200206106</ArticleId><ArticleId IdType="pmc">PMC2173148</ArticleId><ArticleId IdType="pubmed">12196509</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JM, Mansfeld J, Capitanio J, Kutay U, Wozniak RW. Pom121 links two essential subcomplexes of the nuclear pore complex core to the membrane. J. Cell Biol. 2010;191:505&#x2013;521. doi: 10.1083/jcb.201007098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201007098</ArticleId><ArticleId IdType="pmc">PMC3003318</ArticleId><ArticleId IdType="pubmed">20974814</ArticleId></ArticleIdList></Reference><Reference><Citation>Onischenko E, et al. Natively unfolded FG repeats stabilize the structure of the nuclear pore complex. Cell. 2017;171:904&#x2013;917.e19. doi: 10.1016/j.cell.2017.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.033</ArticleId><ArticleId IdType="pmc">PMC5992322</ArticleId><ArticleId IdType="pubmed">29033133</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho K-I, et al. Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes. Dis. Model Mech. 2017;10:559&#x2013;579. doi: 10.1242/dmm.027730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.027730</ArticleId><ArticleId IdType="pmc">PMC5451164</ArticleId><ArticleId IdType="pubmed">28100513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan R, Gerace L, Melchior F. Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J. Cell Biol. 1998;140:259&#x2013;270. doi: 10.1083/jcb.140.2.259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.140.2.259</ArticleId><ArticleId IdType="pmc">PMC2132567</ArticleId><ArticleId IdType="pubmed">9442102</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat. Rev. Mol. Cell Biol. 2005;6:21&#x2013;31. doi: 10.1038/nrm1550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1550</ArticleId><ArticleId IdType="pubmed">15688064</ArticleId></ArticleIdList></Reference><Reference><Citation>Shani, T., Levy, M. &amp; Israelson, A. Assay to measure nucleocytoplasmic transport in real time within motor neuron-like NSC-34 cells. J. Vis. Exp. (2017).10.3791/55676</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5607997</ArticleId><ArticleId IdType="pubmed">28570551</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga A, et al. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS ONE. 2012;7:e43120. doi: 10.1371/journal.pone.0043120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043120</ArticleId><ArticleId IdType="pmc">PMC3416794</ArticleId><ArticleId IdType="pubmed">22900096</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold HC, et al. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep. 2018;8:4606. doi: 10.1038/s41598-018-22858-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22858-w</ArticleId><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Haines JD, et al. Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination. Nat. Neurosci. 2015;18:511&#x2013;520. doi: 10.1038/nn.3953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3953</ArticleId><ArticleId IdType="pmc">PMC4522902</ArticleId><ArticleId IdType="pubmed">25706475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovar DR, Harris ES, Mahaffy R, Higgs HN, Pollard TD. Control of the assembly of ATP- and ADP-actin by formins and profilin. Cell. 2006;124:423&#x2013;435. doi: 10.1016/j.cell.2005.11.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.11.038</ArticleId><ArticleId IdType="pubmed">16439214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash LL, et al. Small-molecule intramimics of formin autoinhibition: a new strategy to target the cytoskeletal remodeling machinery in cancer cells. Cancer Res. 2013;73:6793&#x2013;6803. doi: 10.1158/0008-5472.CAN-13-1593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-13-1593</ArticleId><ArticleId IdType="pubmed">24242070</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013;126:385&#x2013;399. doi: 10.1007/s00401-013-1149-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1149-y</ArticleId><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivadasan R, et al. C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nat. Neurosci. 2016;19:1610&#x2013;1618. doi: 10.1038/nn.4407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4407</ArticleId><ArticleId IdType="pubmed">27723745</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Van Damme P, Van Den Bosch L. Inside out: the role of nucleocytoplasmic transport in ALS and FTLD. Acta Neuropathol. 2016;132:159&#x2013;173. doi: 10.1007/s00401-016-1586-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1586-5</ArticleId><ArticleId IdType="pmc">PMC4947127</ArticleId><ArticleId IdType="pubmed">27271576</ArticleId></ArticleIdList></Reference><Reference><Citation>Minakhina S, Myers R, Druzhinina M, Steward R. Crosstalk between the actin cytoskeleton and Ran-mediated nuclear transport. BMC Cell Biol. 2005;6:32. doi: 10.1186/1471-2121-6-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-6-32</ArticleId><ArticleId IdType="pmc">PMC1215477</ArticleId><ArticleId IdType="pubmed">16120220</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Nonaka T, Suzuki G, Kametani F, Hasegawa M. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. Hum. Mol. Genet. 2016;25:1420&#x2013;1433. doi: 10.1093/hmg/ddw024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw024</ArticleId><ArticleId IdType="pubmed">26908597</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley MD, Bieri G, Kolaitis R-M, Taylor JP, Gitler AD. Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. J. Neurosci. 2014;34:8083&#x2013;8097. doi: 10.1523/JNEUROSCI.0543-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0543-14.2014</ArticleId><ArticleId IdType="pmc">PMC4051967</ArticleId><ArticleId IdType="pubmed">24920614</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahed Z, Soheilypour M, Peyro M, Mofrad MRK. The LINC and NPC relationship - it&#x2019;s complicated! J. Cell Sci. 2016;129:3219&#x2013;3229. doi: 10.1242/jcs.184184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.184184</ArticleId><ArticleId IdType="pubmed">27530973</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J-Y, et al. Sun1 deficiency leads to cerebellar ataxia in mice. Dis. Model Mech. 2015;8:957&#x2013;967. doi: 10.1242/dmm.019240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.019240</ArticleId><ArticleId IdType="pmc">PMC4527285</ArticleId><ArticleId IdType="pubmed">26035387</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F, et al. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat. Genet. 2007;39:80&#x2013;85. doi: 10.1038/ng1927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1927</ArticleId><ArticleId IdType="pubmed">17159980</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekharzadeh B, et al. Tau protein disrupts nucleocytoplasmic transport in alzheimer&#x2019;s disease. Neuron. 2018;99:925&#x2013;940.e7. doi: 10.1016/j.neuron.2018.07.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.07.039</ArticleId><ArticleId IdType="pmc">PMC6240334</ArticleId><ArticleId IdType="pubmed">30189209</ArticleId></ArticleIdList></Reference><Reference><Citation>Paonessa F, et al. Microtubules deform the nuclear membrane and disrupt nucleocytoplasmic transport in tau-mediated frontotemporal dementia. Cell Rep. 2019;26:582&#x2013;593.e5. doi: 10.1016/j.celrep.2018.12.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.12.085</ArticleId><ArticleId IdType="pmc">PMC6335264</ArticleId><ArticleId IdType="pubmed">30650353</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelison GL, Levy SA, Jenson T, Frost B. Tau-induced nuclear envelope invagination causes a toxic accumulation of mRNA in Drosophila. Aging Cell. 2019;18:e12847. doi: 10.1111/acel.12847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12847</ArticleId><ArticleId IdType="pmc">PMC6351838</ArticleId><ArticleId IdType="pubmed">30411463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar JP, Wilkie GS, Tekotte H, Moses K, Davis I. Perturbing nuclear transport in Drosophila eye imaginal discs causes specific cell adhesion and axon guidance defects. Dev. Biol. 2001;240:315&#x2013;325. doi: 10.1006/dbio.2001.0468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/dbio.2001.0468</ArticleId><ArticleId IdType="pubmed">11784066</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent, E. W., Gupton, S. L. &amp; Gertler, F. B. The growth cone cytoskeleton in axon outgrowth and guidance. Cold Spring Harb. Perspect. Biol. 3, pii: a001800 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039926</ArticleId><ArticleId IdType="pubmed">21106647</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H, Yoon BC, Holt CE. Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat. Rev. Neurosci. 2012;13:308&#x2013;324. doi: 10.1038/nrn3210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3210</ArticleId><ArticleId IdType="pmc">PMC3682205</ArticleId><ArticleId IdType="pubmed">22498899</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L-Q, Pennise CR, Rodemer W, Jahn KS, Selzer ME. Protein synthetic machinery and mRNA in regenerating tips of spinal cord axons in lamprey. J. Comp. Neurol. 2016;524:3614&#x2013;3640. doi: 10.1002/cne.24020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24020</ArticleId><ArticleId IdType="pmc">PMC5050069</ArticleId><ArticleId IdType="pubmed">27120118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ET, et al. Dysregulation of mRNA localization and translation in genetic disease. J. Neurosci. 2016;36:11418&#x2013;11426. doi: 10.1523/JNEUROSCI.2352-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2352-16.2016</ArticleId><ArticleId IdType="pmc">PMC5125209</ArticleId><ArticleId IdType="pubmed">27911744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Donlin-Asp PG, Rouanet JP, Bassell GJ, Rossoll W. Deficiency of the survival of motor neuron protein impairs mRNA localization and local translation in the growth cone of motor neurons. J. Neurosci. 2016;36:3811&#x2013;3820. doi: 10.1523/JNEUROSCI.2396-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2396-15.2016</ArticleId><ArticleId IdType="pmc">PMC4812137</ArticleId><ArticleId IdType="pubmed">27030765</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Vande Velde C. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? Front. Cell Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan KE, Gleizes P-E, Bohnsack MT. Nucleocytoplasmic transport of RNAs and RNA-protein complexes. J. Mol. Biol. 2016;428:2040&#x2013;2059. doi: 10.1016/j.jmb.2015.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.09.023</ArticleId><ArticleId IdType="pubmed">26434509</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill SJ, et al. Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc. Natl Acad. Sci. USA. 2016;113:E7701&#x2013;E7709. doi: 10.1073/pnas.1611673113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1611673113</ArticleId><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, et al. C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol. Aging. 2012;33:2528.e7&#x2013;14. doi: 10.1016/j.neurobiolaging.2012.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.06.008</ArticleId><ArticleId IdType="pubmed">22766072</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, et al. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348:1151&#x2013;1154. doi: 10.1126/science.aaa9344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijering E, et al. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytom. A. 2004;58:167&#x2013;176. doi: 10.1002/cyto.a.20022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.20022</ArticleId><ArticleId IdType="pubmed">15057970</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijering E, Dzyubachyk O, Smal I. Methods for cell and particle tracking. Meth Enzym. 2012;504:183&#x2013;200. doi: 10.1016/B978-0-12-391857-4.00009-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-391857-4.00009-4</ArticleId><ArticleId IdType="pubmed">22264535</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671&#x2013;675. doi: 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Nana AL, Yokoyama JS, Seeley WW. C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies. Acta Neuropathol. 2019;137:1&#x2013;26. doi: 10.1007/s00401-018-1921-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1921-0</ArticleId><ArticleId IdType="pmc">PMC6546170</ArticleId><ArticleId IdType="pubmed">30368547</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, et al. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:459&#x2013;474. doi: 10.1007/s00401-017-1793-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, et al. Post-translational O-GlcNAcylation is essential for nuclear pore integrity and maintenance of the pore selectivity filter. J. Mol. Cell Biol. 2016;8:2&#x2013;16. doi: 10.1093/jmcb/mjv033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjv033</ArticleId><ArticleId IdType="pmc">PMC4710208</ArticleId><ArticleId IdType="pubmed">26031751</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer RB, Herzog NK. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line. BioTechniques. 1995;19:192&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">8527134</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>